Key facts
- This page summarizes Karen Wendel's Form 4 filing for Beneficient (BENF).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Nov 2024, 17:36.
Karen Wendel - 21 Nov 2024 Form 4 Insider Report for Beneficient (BENF)
- Reporting relationship
- Director
- Issuer ticker
- BENF
- Reported as of
- 21 Nov 2024
- Net transaction value
- $0
- Reporting owner signature
- /s/ David B. Rost, Attorney-in-fact for Karen Wendel
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Karen Wendel filed Form 4 for Beneficient (BENF) on 25 Nov 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BENF
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +207,317
- Change %
- Price
- $0.000000
- Shares after
- 207,317
- Date
- 21 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BENF
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- Price
- $0.000000
- Shares after
- 100,000
- Date
- 21 Nov 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 100,000
- Exercise price
- $0.8200
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 207,317 shares of Class A common stock, par value $0.001 ("Class A common stock"), of Beneficient (the "Issuer") issuable upon the settlement of an award of 207,317 restricted stock units ("RSUs") granted pursuant to the Beneficient 2023 Equity Incentive Plan ("2023 Equity Incentive Plan") to Karen Wendel (the "Reporting Person") on November 21, 2024. Such award of RSUs to the Reporting Person will vest in four equal installments on the last day of each calendar quarter over a one-year period from the date of grant, provided that the Reporting Person is providing services to the Issuer through each applicable vesting date.
Footnote F2
The shares underlying this stock option were granted pursuant to the 2023 Equity Incentive Plan and will vest and become exercisable in eight equal installments on the last day of each calendar quarter over a two-year period from the date of grant, provided that the Reporting Person is providing services to the Issuer through each applicable vesting date.